The vaccine is not a silver bullet.

Realistically, it may help to control or reduce the Covid cases but Covid is here to stay. There are still many unanswered questions as to whether how many asymptomatic cases detected in the test group, (and the danger is that Covid can spread quietly unlike SARS, H1N1, etc), whether it induce protection on different ethnic group, gender, age (as in many cases it is harder to induce immune response in older people which are at highest risk), what is the degradation rate of the vaccine efficacy (and for your info, flu vaccine efficacy is merely 40% to 60% and it normally lasted around 4 months which is good enough for winter or flu season but Covid linger throughout the year).

Adverse vaccine news will soon come after detail study and peer review because many questions cannot be addressed in such a such time without deliberate long term study. And, realistically, maybe average 50% world population will take vaccine, and no more than that. To-date, what you are being fed are sales-pitch by the big pharma, like a miracle drug in the market which everyone is hoping for but only to be disappointed again and again.

Covid is here to stay and impose more realistic measure to control the widespread. Vaccine alone is not the answer. It is just human nature believing that there is a miracle discovery that can resolve their problem just like that.

VACCINE WILL NOT BE ENOUGH TO STOP PANDEMIC, SAYS WHO CHIEF
-----------------------------------------------------------
AFP |Monday

GENEVA - The head of the World Health Organization said Monday that a vaccine would not by itself stop the coronavirus pandemic.

The pandemic is raging months after it broke out, with infections soaring past 54 million and claiming more than 1.3 million lives.

"A vaccine will complement the other tools we have, not replace them," director-general Tedros Adhanom Ghebreyesus said. "A vaccine on its own will not end the pandemic."

The WHO's figures for Saturday showed that 660,905 coronavirus cases were reported to the UN health agency, setting a new high water mark.

That number, and the 645,410 registered on Friday, surpassed the previous daily record high of 614,013 recorded on 7 November.

Tedros said that supplies of the vaccine would initially be restricted, with "health workers, older people and other at-risk populations (to) be prioritised. That will hopefully reduce the number of deaths and enable the health systems to cope."

But he warned: "That will still leave the virus with a lot of room to move. Surveillance will need to continue, people will still need to be tested, isolated and cared for, contacts will still need to be traced... and individuals will still need to be cared for."

@freetospeak- fully agree- Stanley will make sure SUPER don't fall below RM7-00. This is to ensure admittance to the prestigious KLCI composite index.- the cut off is on 23rd NOV.
-------------------------------------------------------------
@ freetospeak.- if stanley wan klci index..7 mus hold..lo...anyway this weekend sure above 7 ...kossan no cash one cannot fight...supermax cash rich enuff to sbb 10% market cap...and list them on singapore and still can earn some pocket money...so it will go up no matter how u throw...

Dont paric folks - GLOVES will be in big demand as COVID will be around for a long time.
The vaccine - its not a CURE just a PREVENTIVE measure.

Today is knee jerk reaction only.

The GLOVES sector is still the BEST and MOST profitable sector in BURSA.

Dont' stop believin.

https://ewn.co.za/2020/11/16/vaccine-will-not-be-enough-to-stop-pandemic-says-who-chief

VACCINE WILL NOT BE ENOUGH TO STOP PANDEMIC, SAYS WHO CHIEF

AFP |Monday

GENEVA - The head of the World Health Organization said Monday that a vaccine would not by itself stop the coronavirus pandemic.

The pandemic is raging months after it broke out, with infections soaring past 54 million and claiming more than 1.3 million lives.

"A vaccine will complement the other tools we have, not replace them," director-general Tedros Adhanom Ghebreyesus said. "A vaccine on its own will not end the pandemic."

The WHO's figures for Saturday showed that 660,905 coronavirus cases were reported to the UN health agency, setting a new high water mark.

That number, and the 645,410 registered on Friday, surpassed the previous daily record high of 614,013 recorded on 7 November.

Tedros said that supplies of the vaccine would initially be restricted, with "health workers, older people and other at-risk populations (to) be prioritised. That will hopefully reduce the number of deaths and enable the health systems to cope."

But he warned: "That will still leave the virus with a lot of room to move. Surveillance will need to continue, people will still need to be tested, isolated and cared for, contacts will still need to be traced... and individuals will still need to be cared for."

If this really happen as planned - RM0.70 in December is not a problem.
----------------------------------
"On the 24th of November, they will be started testing and trial run of production.
Expected to start production of gloves in early December
Total of 13 production lines to produce Nitrile Glove
Estimated sales price USD $90 per 1000pcs, spot order USD 150+-. The gloves in China sell for about USD $130
Cost USD $22 per 1000 pcs"

AT will stabilise around 45-50 sen this week. Be patient. when production start in December 65-75 sen. One day 5-6 sen is good enough. expect pull back from time to time.
Dont panic ya.
No need limit up lah. Nanti semua orang cash out and cabut.

Just my 2 sen ya.

Dont worry Kenie, tomorrow sure gap up due to massive publicity and bright prospects of ALL glove makers including K Plus. Just relax and enjoy the ride till AT produce their first glove in late December. No hard feelings ya Bro Kenie.

We blew it': U.S. reaches 'explosive' COVID-19 spread as virus is nearly impossible to control, experts say
-------------------------------------
Sat, November 14, 2020,
With COVID-19 cases increasing in 46 states, 10 of which broke single-day records for new cases on Thursday, America has officially entered what experts refer to as the “exponential” phase of spread — a rapid multiplying of cases that can’t be contained through traditional measures. On Thursday alone, the U.S. saw 160,000 new cases of the virus, more than any day since the pandemic began.

Huat Arrrr
------------------------------
Posted by MadCow75 > Nov 15, 2020 11:28 PM | Report Abuse

kenie, so AT TP RM2.29... Huray... Huat ar!!!!!

@ YSL, fully agree.

Info is AT already spend 120mil investment
Fact is LKL partnership with AT sell glove
LKL many China customer, currently China selling min USD130 per 1000 pieces
Easy for AT to sell if production line run next month
Fact is factory was build up, uncle K was there witness with TY team, LKL boss and few IB investment.
Fact is AT was the only company that really build up with investment 120mil comparing with those company only issue statement yet nothing done.
So guys, calculate your own risk.

All visitors could see the glove factory construction is near completion. The factory will start to produce medical glove next month. All visitors were given the following keynotes:
----------------------------------------------------------------
On the 18th of November the material of glove will arrive.
The raw materials come from Taiwan and Thailand, so there will be no shortage of raw materials. There will be 3-4 suppliers.
On the 24th of November, they will be started testing and trial run of production.
Expected to start production of gloves in early December
Total of 13 production lines to produce Nitrile Glove
Estimated sales price USD $90 per 1000pcs, spot order USD 150+-. The gloves in China sell for about USD $130
Cost USD $22 per 1000 pcs
The land next to the factory belongs to FINTECH and AT will help to manage on behalf and earn management fees
LKL International Berhad is one of AT glove distributor, and other companies will help AT sell gloves since hot demand for medical gloves.
The company expects to be profitable with RM180mil in 2021
The production volume will reach $2.6b in April 2021, and $3.2B gloves later
The company uses cash to build a glove factory and no debts involved
All employees are local, there will be a total of 240 employees. After completing all production lines, there will be 1,200 employees
FDA cert is expected to be Jun Jul 2021
CE certificate is expected to be obtained this month

Profit Valuation

Based on company estimation of $180Mil profit before tax, after tax will be $150Mil, total issued Shares = 3,253Mil

EPS would be 4.6 cents. Based on P/E 15 my immediate target price is 70 sen. If based on P/E 20 the target price will be 92 sen.

Discovery of Vaccines

Many world-famous pharmaceutical companies are at various stages of the discovery of vaccines to overcome the Covid 19 virus. Many scientists predicted the vaccine will be available soon. To be effective in stopping the spread of the virus, at least 70% of the population of the world required to be vaccinated. It will take a long time to produce so much of vaccines. In fact, to vaccinate so many people, a lot more medical workers will be required and all of them have to wear medical gloves to do the injections. As a result, the demand for medical gloves will continue to increase.

Unfortunately, there are many short-sighted investors who are afraid that the discovery of the vaccine would reduce the demand for medical glove, sold their holdings and miss this golden opportunity to make more profit.

SAMSUNG ASIA EQUITY FUND HAS THE FOLLOWING SHARES IN THEIR PORTFOLIO

Top 10 Holdings (% of NAV)

1 WILMAR INTERNATIONAL LTD...........8.12
2 TOP GLOVE CORP BHD......................7.67
3 CHAROEN POKPHAND FOODS..........5.55
4 HARTALEGA HOLDINGS BHD.............5.46
5 PHILIPPINE LONG DISTANCE TEL......4.91
6 SEA LTD-ADR......................................4.88
7 SUPERMAX CORP BHD.......................4.67-----SUPER TO THE MAX
8 KOSSAN RUBBER INDUSTRIES..........4.24
9 Carabao Group PCL.............................4.17
10 INDOFOOD CBP SUKSES....................3.52

Top 4 -Most read Blogs today. Its all about AT- Set to Surge tomorrow due to FOMO.
--------------------------------------------------
1. Is AT really worth what it is, or much much more? JL's Stock Picks and Coverages
2. AT Systematization Berhad (0072) – From Zero to Hero!
3. AT Glove production capacity - Koon Yew Yin Koon Yew Yin's Blog
4. AT – The winning horse after the race? The 'Right' Man

Sure gap up tomorrow!

Uncle KYY said - AT s an EXCEPTION to his stock selection golden rule.
------------------------------------------------------------------
All successful investors must not be so rigid and not flexible. They must have some imagination, foresight and willing to take some calculated investment risk. Now is the best time to buy before the company reports actual profit. When ATS starts to report profit from its glove sales, its share price should be much higher. You cannot imagine the share price of a medical glove manufacturer selling below Rm 1.00.

But in the case of ATS, I started buying it before I can see any actual profit. There is an old English saying “exception proves the rule”. If there is no exception there is no rule. If there is a rule there must be an exception. ATS is an exception to my stock selection golden rule.

https://klse.i3investor.com/blogs/trm/2020-11-15-story-h1536431135-AT_The_winning_horse_after_the_race.jsp

https://klse.i3investor.com/blogs/trm/2020-11-15-story-h1536431135-AT_The_winning_horse_after_the_race.jsp

https://klse.i3investor.com/blogs/trm/2020-11-15-story-h1536431135-AT_The_winning_horse_after_the_race.jsp

Interesting Article on AT.

https://klse.i3investor.com/blogs/trm/2020-11-15-story-h1536431135-AT_The_winning_horse_after_the_race.jsp

@ YSL Wah! buat kerja 24 jam- Cuti oso kerja - December sure can ready!

Thanks YSL! - our reporter at site in Chemor - AT Glove factory.
-----------------------------------------------------------
Posted by YSL76 > Nov 14, 2020 11:43 AM | Report Abuse

Got construction guy Sana, worker car also Ada, lorry in out also ada

LKL and AT Systematization ink deal to market and distribute gloves
------------------------------------------------
KUALA LUMPUR : Medical and healthcare equipment provider LKL International Bhd has inked an agreement with AT Systematization Bhd to market, sell and distribute natural rubber latex gloves and nitrile gloves.

In a joint statement today, the firms said the agreement was signed between LKL unit LKL Advance Metaltech Sdn Bhd (LKLAM) and AT Glove Engineering Sdn Bhd (ATGE).

The agreement is for an initial period of one year from the agreement date and renewable thereafter, in line with the expected commencement of ATGE’s glove manufacturing production in early December 2020.

The gloves would be mainly distributed to hospitals and healthcare providers, with a targeted volume of up to 2.6 billion pieces per year.

LKL managing director Lim Kon Lian said AT Systematization would be able to tap into the former’s extensive distribution network within the healthcare industry, both in Malaysia and internationally.

“This is also timely as it enhances our capabilities in fulfilling urgent market requirements for gloves as we continue to receive increasing enquiries from existing and potential customers,” he said.

Meanwhile, AT Systematization executive director Mak Siew Wei said the strategic partnership with LKL will bolster the firm’s pursuit to become a leading glove player, given LKL’s experience in distribution and its good client base.

“We are on track to reach a production capacity of 2.6 billion glove pieces per annum. On top of these, we have begun preliminary planning works for additional glove production lines that would further raise our production capacity to facilitate additional demand.

“We are positive that this will pave the way for greater collaboration with LKL International in the near future,” he said.

KUALA LUMPUR The Edge (Nov 14): AT Systematization Bhd (ATS) continued to see a surge in trading activity in the past trading week with its total weekly trading volume exceeding the 10 billion mark, likely driven by the craze for rubber glove stocks.

Its wholly-owned subsidiary AT Glove Engineering Sdn Bhd (AGESB) had entered into a supply contract with Ripcol Engineering Sdn Bhd (RESB), which would see RESB act as AGESB’s contractor to design, fabricate, install, test and commission six rubber glove production lines.

Setting up the six lines would cost ATS some RM36.15 million. In total, AGESB would produce 928 million pieces of rubber gloves a year with the six lines — 103 million pieces from the single former dipping line and 825 million pieces from the double former dipping lines.

The fifth double dipping former line is expected to be installed and commissioned by April next year. The company released an update on the rubber glove venture in late October and it had given earnings guidance on the new venture, expecting the rubber glove business to contribute annual revenue of RM860 million, which is over 40 times the RM20 million achieved in its financial year ended March 31, 2020 (FY20).

Profit Valuation of AT Gloves

Based on company estimation of $180Mil profit before tax, after tax will be $150Mil, Shares = 3,253Mil

EPS would be 4.6 cents.

Projected PE = 20

The target price of AT will be RM0.92. Potential Upside 268% based on the today closing price of RM0.25.

LKL and AT Systematization ink deal to market and distribute gloves
Surin Murugiah

theedgemarkets.com

KUALA LUMPUR (Nov 6): Medical and healthcare equipment provider LKL International Bhd has inked an agreement with AT Systematization Bhd to market, sell and distribute natural rubber latex gloves and nitrile gloves.

In a joint statement today, the firms said the agreement was signed between LKL unit LKL Advance Metaltech Sdn Bhd (LKLAM) and AT Glove Engineering Sdn Bhd (ATGE).

The agreement is for an initial period of one year from the agreement date and renewable thereafter, in line with the expected commencement of ATGE’s glove manufacturing production in early December 2020.

YES, totally agree with you. @ John farmer.
-----------------------------
today can hold is good enough, next week when kky,tty,dr edwin and other sifu make buy call to their follower monday can easily gap up very very big... and then smart retailer come in... then friend of friend come in ,then uncle auntie from pasar malam come in.. by then already 0.50 you will be hesitating to go in or not while other already enjoy 100%-400% upside

Fauci said. , "I doubt we are going to eradicate this pandemic. I think we need to plan that this is something we may need to maintain control over chronically. It may be something that becomes endemic, that we have to just be careful about,"

DATO' NIK ISMAIL BIN DATO' NIK YUSOFF (a company director) acquired 200,000 shares on 09-Nov-2020.

Insider / director also bought yesterday.

Announcement on loan moratorium extension will be made soon.
------------------------------------------------------
Wednesday, 11 Nov 2020

KUALA LUMPUR: An official announcement on the loan moratorium extension for all, and the one-off withdrawal from Account 1 of the Employee's Provident Fund (EPF) will be made soon, claims Datuk Seri Shahidan Kassim.

The Perikatan Nasional Backbenchers’ Club (PNBBC) chairman hinted that an agreement in principle had been reached on these issues and Finance Minister Tengku Zafrul Tengku Abdul Aziz is expected to make the changes before the winding up of Budget 2021.

“Maybe the Finance Minister will make an official announcement even before the winding up of the budget, ” he told a press conference in Parliament.

Pfizer's CEO sold $5.6 million in stock on same day of vaccine news
----------------------------------------------------------
Pfizer CEO Albert Bourla sold $5.6 million worth of stock on Monday — the same day it said its and BioNTech's coronavirus vaccine showed 90% effectiveness in preliminary results, which saw the company's stock soaring almost 8%.

Govt, Opposition MPs united in support of loan moratorium extension
--------------------------------
Tuesday, 10 Nov 2020

KUALA LUMPUR, Nov 10 — Members of the Parliament from the government and the Opposition bloc have expressed support for the proposed extension of the loan moratarium period until June 2021 to be included in Budget 2021 to help the people cope with Covid-19.

Datuk Seri Ahmad Maslan (BN-Pontian) suggested that after the six-month period ends, those with loans of RM500,000 or less be given an automatic deferral of payment for another three to six months if Covid-19 still spreading.

“The figure (RM500,000) can be changed to help more people,” he said when debating the Supply Bill 2021 in the Dewan Rakyat today.

Money to flow back to GLOVES from BANKS today as loan moratorium extension look imminent.

Pfizer Vaccine Still in early stages of Stage 3 - need 2 years of monitoring to ensure SAFETY.
------------------------------------------------------
Although the data is promising, Bowman (Canadian Biotec Professor) said it’s best that everyone remains “cautiously optimistic” as there are still a lot of unknowns.

“We have to be quite cautious. We are looking at public relations from a pharmaceutical company whose primary goal is marketing and profit,” he said. “I am not saying I don’t believe it, but you have to realize that the full data has not been released. They are telling us what the data says, so experts still need to review it.”The vaccine still has to complete Phase Three clinical trials and that data has to be submitted for scientific peer review

The Phase Three clinical trial of the vaccine began on 27 July and has enrolled 43,538 participants to date, 38,955 of whom have received a second dose of the vaccine, as of 8 November.

The clinical trial will continue until 164 volunteers develop COVID-19 - a number that the Food and Drug Administration (FDA) has agreed is enough to tell if the vaccine was working.

Researchers are including new study endpoints to characterise the vaccine's performance, such as in patients with severe COVID-19 disease or who had COVID-19 before.

Participants will also continue to be monitored for long-term protection and safety for a total of TWO years after their second dose.

Hi Folks, during H1N1 pandemic, 5 vaccines were approved by WHO, the share price of Topglov still move up north for 10 months. Until today, all 5 vaccines also failed. Vaccine was available in China a few months ago, the share price of Intco hit limit up yesterday. The final decision is always yours. Stay calm and talk with facts and figures. Comments by Mr TB OOI.

Major uncertainties are over- Supermax posed to SURGE. Here re the positives

1. AGM 2nd December.

2. Share Dividend ex 7 Dec .

3. US President BIDEN elected ie Healthcare spending boosted. Biggest uncertainty is over.

4. Malaysia Government reiterate its supportive stands on maintaining local Glove industry competitiveness by not imposing windfall tax. Second uncertainty is over.

5. Big donation in fighting Covid is a huge CSR boost. Fund and investor will view it positively.

6. Emerging market have seen continous flowing in of fund lately.

7. Inclusion of SUPRMAX to the KLCI Composit index in December

SUPERMAX- A COMPELLING BUY- Take a look at the figures below-
-----------------------------------------------
Supermax current PE is only 20 if compared to HARTA 62 and TOPGLOVE 37.

Supermax PE will be around 11 (base on current price of 9.70) by next QTR result to be annouced in JAN after it is KLCI indexed in Dec. The 5 yrs mean for KLCI indexed Glove stock should be more than 20. More fund will be rebalancing their portfolio to include Supermax into their investment.

By January, after the Qtr 2 result. The trailing PE :

QTR 2 1.1 bil (est) eps = 41 sen
QTR 1 30.58
QTR 4 15.29
QTR 3 2.71
Total 89.58 sen

PE = 9.78/0.8958 = 10.9
PE 20 = rm18.00 Market caps = 48 billion (78% of Harta Caps)

SUPERMAX FAIR VALUATION- RM18-00

https://klse.i3investor.com/blogs/freetospeak/2020-11-08-story-h1535513315-SUPERMAX_EVOLVING_GLOBALLY.jsp

https://klse.i3investor.com/blogs/freetospeak/2020-11-08-story-h1535513315-SUPERMAX_EVOLVING_GLOBALLY.jsp

https://klse.i3investor.com/blogs/freetospeak/2020-11-08-story-h1535513315-SUPERMAX_EVOLVING_GLOBALLY.jsp

https://klse.i3investor.com/blogs/freetospeak/2020-11-08-story-h1535513315-SUPERMAX_EVOLVING_GLOBALLY.jsp

https://klse.i3investor.com/blogs/freetospeak/2020-11-08-story-h1535513315-SUPERMAX_EVOLVING_GLOBALLY.jsp

https://klse.i3investor.com/blogs/freetospeak/2020-11-08-story-h1535513315-SUPERMAX_EVOLVING_GLOBALLY.jsp

https://klse.i3investor.com/blogs/freetospeak/2020-11-08-story-h1535513315-SUPERMAX_EVOLVING_GLOBALLY.jsp

Another excellent article by Bro Freetospeak, our brilliant SUPERMAX ambassador.

'Generous donations' substantially smaller than windfall tax would have been as per Malaysian Institute of Accountants president Veerinderjeet Singh
----------------------------------------------------------

The generous donations by Kossan Rubber Industries Bhd, Top Glove Corp Bhd, Hartalega Holdings Bhd and Supermax Corp Bhd of RM400 million to the Government’s Covid-19 fund to battle the pandemic is substantially smaller than the funds that would have been recouped through the expected introduction of a windfall tax.

Absolutely good news for the BIG 4.

Supermax Corporation Bhd will likely be featured as the FTSE Bursa Malaysia KLCI (FBM KLCI) constituents in its next review following the rise in its market capitalisation.

The next review of the FBM KLCI constituents is expected to be in November/December 2020, using share prices based on market close on Nov 23.

Maybank IB said the constituent change/s would be implemented after the market closes on the third Friday in December, which is on the 18th and would be effective on Monday, Dec 21, 2020.

Implementation of Windfall Tax will only KILL the industry- Please read on-
----------------------------------------------------
Ministry drafts plans to keep Malaysia's leadership in rubber glove sector
Bernama

November 05, 2020 23:48 pm +08

KUALA LUMPUR (Nov 5): The Ministry of Plantation Industries and Commodities (MPIC), through the Malaysian Rubber Council (MRC), is always drafting and implementing short-, medium- and long-term plans to maintain Malaysia's global leadership in the production of rubber gloves.

Minister Datuk Dr Mohd Khairuddin Aman Razali said that under the short- and medium-term plans, MRC will continue to carry out promotional activities overseas, such as participating in international trade expositions together with industry players, organise trade missions and educational seminars, business matching and advertising in international media.

"These promotional activities not only include leading rubber glove markets such as the United States and Europe but also cover most populous countries with high potential like China, India, Indonesia, Vietnam, Brazil and Russia,” he said during the question-and-answer session in the Dewan Rakyat today.

Conclusion
------------
Chance of Windfall Tax is virtually ZERO.

Here is an interesting article on windfall tax.

https://www.linkedin.com/pulse/malaysias-budget-wheres-windfall-kishenjeet-dhillon/?published=t

Hope the Maybank Kim Eng Clowns read this article.

SUPER MAX can easily take control of this sleeping Giant for a song and turn it into a MASSIVE GIANT in properties and gloves.